3
Views
17
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Mutations of the Platelet-Derived Growth Factor Receptor That Cause a Loss of Ligand-Induced Conformational Change, Subtle Changes in Kinase Activity, and Impaired Ability To Stimulate DNA Synthesis

, &
Pages 4473-4478 | Received 27 Apr 1989, Accepted 12 Jul 1989, Published online: 01 Apr 2023

LITERATURE CITED

  • Besnier, P., J. E. Murphy, P. C. George, F. Qui, P. J. Bergold, L. Lederman, H. W. Snyder, Jr., D. Brodeur, E. E. Zuckerman, and W. D. Hardy. 1986. A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature (London) 320:415–421.
  • Coussens, L., C. Van Beveren, D. Smith, E. Chen, R. L. Mitcheu, C. M. Isacke, I. M. Verma, and A. Ullrich. 1986. Structural alteration of viral homologue of receptor proto-oncogene fins at carboxyl terminus. Nature (London) 320:277–280.
  • Debant, A., E. Clauser, G. Ponzio, C. Filloux, C. Auzan, J.-O. Contreres, and B. Rossi. 1988. Replacement of insulin receptor tyrosine residues 1162 and 1163 does not alter the mitogenic effect of the hormone. Proc. Natl. Acad. Sci. USA 85:8032–8036.
  • Ek, B., and C.-H. Heldin. 1982. Characterization of a tyrosine-specific kinase activity in human fibroblast membranes stimulated by platelet-derived growth factor. J. Biol. Chem. 257:10486–10492.
  • Escobedo, J. A., P. J. Barr, and L. T. Williams. 1988. Role of tyrosine kinase and membrane-spanning domains in signal transduction by the platelet-derived growth factor receptor. Mol. Cell. Biol. 8:5126–5131.
  • Escobedo, J. A., M. T. Keating, H. E. Ives, and L. T. Williams. 1988. Platelet-derived growth factor receptors expressed by cDNA transfection couple to a diverse group of cellular responses associated with cell proliferation. J. Biol. Chem. 263:1482–1487.
  • Escobedo, J. A., and L. T. Williams. 1988. A PDGF receptor domain essential for mitogenesis but not for many other responses to PDGF. Nature (London) 335:85–87.
  • Frackelton, A. R., P. M. Tremble, and L. T. Williams. 1984. Evidence for the platelet-derived growth factor-stimulated tyrosine phosphorylation of the platelet-derived growth factor receptor in vivo. J. Biol. Chem. 259:7909–7915.
  • Hart, C. E., J. W. Forstrom, J. D. Kelly, R. A. Seifert, R. A. Smith, R. Ross, M. J. Murray, and D. F. Bowen-Pope. 1988. Two classes of PDGF receptor recognize different isoforms of PDGF. Science 240:1529–1531.
  • Heldin, C.-H., G. Backstrom, A. Ostman, A. Hammacher, L. Ronnstrand, K. Rubin, M. Nister, and B. Westermark. 1988. Binding of different forms of PDGF to human fibroblasts: evidence for two separate receptor types. EMBO j. 7:1387–1393.
  • Herrera, R., and O. M. Rosen. 1986. Autophosphorylation of the insulin receptor in vitro. J. Biol. Chem. 261:11980–11985.
  • Keating, M. T., J. A. Escobedo, and L. T. Williams. 1988. Ligand activation causes a phosphorylation-dependent change in platelet-derived growth factor receptor conformation. J. Biol. Chem. 263:12805–12808.
  • Keating, M. T., and L. T. Williams. 1987. Processing of the platelet-derived growth factor receptor. J. Biol. Chem. 262:7932–7937.
  • Lyman, S. D., and L. R. Rohrschneider. 1987. Analysis of functional domains of the v-fms-encoded protein of Susan McDonough strain feline sarcoma virus by linker insertion mutagenesis. Mol. Cell. Biol. 7:3287–3296.
  • Matsui, T., M. Heidaran, T. Miki, N. Popescu, W. La Rochelle, M. Kraus, J. Pierce, and S. Aaronson. 1989. Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science 243:800–804.
  • Nishimura, J., J. S. Huang, and T. F. Duel. 1982. Platelet-derived growth factor stimulates tyrosine-specific protein kinase activity in Swiss mouse 3T3 cell membranes. Proc. Natl. Acad. Sci. USA 79:4303–4307.
  • Patschinsky, T., T. Hunter, F. S. Esch, J. A. Cooper, and B. M. Sefton. 1982. Analysis of the sequence of amino acids surrounding sites of tyrosine phosphorylation. Proc. Natl. Acad. Sci. USA 79:973–977.
  • Rosen, O. M., R. Herrera, Y. Olowe, L. M. Petruzzelli, and M. H. Cobb. 1983. Phosphorylation activates the insulin receptor tyrosine protein kinase. Proc. Natl. Acad. Sci. USA 80:3237–3240.
  • Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463–5467.
  • Schimmel, P., M. Jasin, and L. Regan. 1984. Size polymorphism and the structure of aminoacyl-tRNA synthetases. Fed. Proc. 43:2987–2990.
  • Sherr, C. J., C. W. Rettenmier, R. Sacca, M. F. Roussel, A. T. Look, and E. R. Stanley. 1985. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41:665–676.
  • Smart, J. E., H. Oppermann, A. P. Czernilofsky, A. F. Purchio, R. L. Erikson, and J. M. Bishop. 1981. Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src). Proc. Natl. Acad. Sci. USA 78:6013–6017.
  • Wang, J. Y. J.. 1985. Isolation of antibodies for phosphotyrosine by immunization with a v-abl oncogene-encoded protein. Mol. Cell. Biol. 5:3640–3643.
  • White, M. F., J. N. Livingston, J. M. Backer, V. Lauris, T. J. Dull, A. Uurich, and C. R. Kahn. 1988. Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity. Cell 54:641–649.
  • Yarden, Y., J. A. Escobedo, W.-J. Kuang, T. L. Yang-Feng, T. O. Daniel, P. M. Tremble, E. Y. Chen, M. E. Ando, R. N. Harkins, U. Francke, V. A. Fried, A. Ullrich, and L. T. Williams. 1986. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature (London) 323:226–232.
  • Yarden, Y., W. J. Kuang, T. L. Yang-Feng, L. Coussens, S. Munemitsu, T. J. Duu, E. Chen, J. Schlessinger, U. Francke, and A. Ullrich. 1987. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO j. 6:3341–3351.
  • Zoller, M. J., and M. Smith. 1982. Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA. Nucleic Acids Res. 10:6487–6500.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.